Vascular injury refers to injury to a blood vessel (artery and veins). Moreover, vascular surgeon categorizes these injuries by the type of trauma that caused them such as blunt or penetrating injury. When blood vessel is stretched or crushed it results in blunt injury, whereas, when blood vessel is punctured, torn or severed, it results in penetrating injury. In addition, blunt and penetrating injury may lead to life-threatening hemorrhage. Sometimes, blood clots can be critical critical, when it get breaks off and travel to other parts of the body such as lungs and brain, can cause Ischemic strokes, pulmonary embolism.

Medical therapy, minimally-invasive catheter procedures, and surgical reconstruction are some treatment option for vascular injury, while angiogram, segmental pressure test, computed tomography angiography (CTA), duplex ultrasound are common vascular tests, which are conducted by the healthcare professional for the vascular injury diagnosis.

Global Vascular Injury Treatment Market Drivers

The global vascular injury treatment market is expected to witness significant growth over the forecast period due to increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases. For instance, in 2019, Mayo Clinic Health System and OU Children's Hospital entered into a collaboration for rare heart disease research (Hypoplastic Left Heart Syndrome). In addition, they are collaborating with the number of hospitals globally for the treatment of rare heart disease. Moreover, Children's Hospital at OU Medicine collaborated with five other Hypoplastic Left Heart Syndrome (HLHS) Consortium members, including Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and the Children's Hospital Colorado.

Moreover, in 2018, Mayo Clinic Health System entered into collaboration with Eko to develop data-driven technology that will help physician to detect potential dangerous heart diseases. Also, Eko and Mayo Clinic has announced to develop and commercialize a machine based algorithm that will help to screen the patient for the presence of a low ejection fraction (a weak heart pump). Hence, increasing launches of new technology for detection of heart related disease is expected to propel growth of the global vascular injury treatment market over the forecast period. For instance, according to the WHO, 17.9 million people die each year from cardiovascular disease. Therefore, increasing prevalence of the cardiovascular disease is one of the factors that is expected to drive growth of the global vascular injury treatment market over the forecast period.

Global Vascular Injury Treatment Market Restraints

However, high cost associated with the vascular disease treatment is one of the major factors that is expected to hamper growth of the global vascular injury treatment market. For instance, for peripheral artery disease (PAD) related non-coronary procedures, average cost accounts for US$ 729. In addition, for antihypertensive medication, average cost is US$ 313, while for lipid-lowering therapy, average cost accounts for US$ 207. Moreover, according to the American Heart Association (AHA), in 2035, in U.S, total cost for the treatment of cardiovascular is expected to reach US$ 1.1 trillion. Therefore, high cost for the treatment of vascular disease is expected to hamper growth of the global vascular injury treatment market.

Global Vascular Injury Treatment Market Regional Analysis

North America is expected to account for highest market share over the forecast period in global vascular injury treatment market. This is attributed to increasing prevalence of vascular disease such as cardiovascular disease in the region, which is further expected to drive growth of the North America market. For instance, according to the American Heart Association (AHA), in 2017, 116.4 million of U.S adults suffered from hypertension. According to the same source, by 2035, over 130 million adults of U.S population are expected to suffer from some form of cardiovascular disease.

Asia Pacific is expected to exhibit highest CAGR over the forecast period. This is attributed to increase in the occurrence of trauma due to the increase in the road traffic is the factor that are expected to drive growth of the global vascular injury treatment market in the region. For instance, according to the WHO, over 90% road traffic death occur in low and middle income countries.

Global Vascular Injury Treatment Market Key Players

Key players operating in the global vascular injury treatment market include Medtronic plc, Cardinal Health, Inc., Boston Scientific Corporation, and Teleflex Inc., 3M, Becton, Dickinson, and Company.

Market Taxonomy:

On the basis of device, the global vascular injury treatment market is segmented into:

Instruments
Consumables

On the basis of injury type, the global vascular injury treatment market is segmented into:

Spasm
Thrombosis
Arteriovenous (AV) Fistula
Contusion/Intimal Flap
Others

On the basis of end users, the global vascular injury treatment market is segmented into:

Ambulatory Surgical Centers
Hospitals
Clinics
Others

On the basis of region, the global vascular injury treatment market is segmented into:

North America
Latin America
Europe
Middle East
Asia Pacific
Africa

About Author

Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.